SCHEMBL9713719

SCHEMBL9713719

CCOc1c(CC)c(OC(=O)Cc2ccccc2)c2cc(Cl)ccc2c1OC(=O)Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.43
ABCB11 O95342 1/20 0.41
ALOX15 P16050 1/20 0.41
CNR1 P21554 1/20 0.39
TP53 P04637 1/20 0.38
HPGD P15428 1/20 0.38
ATM Q13315 1/20 0.38
PTGER4 P35408 5/20 0.37
CYP1A2 P05177 2/20 0.37
CYP2D6 P10635 2/20 0.37
UCHL1 P09936 1/20 0.37
USP5 P45974 1/20 0.37
USP4 Q13107 1/20 0.37
SENP1 Q9P0U3 1/20 0.37
LMNA P02545 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTT P42858 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9713901 0.84 ABCB11 (0.43) SMN1; SMN2ABCB11CNR1TP53HPGD
SCHEMBL9643164 0.82 ABCB11 (0.62) SMN1; SMN2ABCB11ALOX15TP53ATM
SCHEMBL10502162 0.81 PTGER4 (0.47) SMN1; SMN2ABCB11ALOX15CNR1TP53
SCHEMBL10504035 0.78 ABCB11 (0.44) SMN1; SMN2ABCB11ALOX15CNR1HPGD
SCHEMBL9449155 0.77 ABCB11 (0.52) SMN1; SMN2ABCB11ALOX15HPGDATM
SCHEMBL9641852 0.76 ABCB11 (0.48) SMN1; SMN2ABCB11ATMMEN1KMT2A
SCHEMBL9643189 0.76 ABCB11 (0.60) SMN1; SMN2ABCB11ALOX15TP53LMNA
SCHEMBL9643528 0.76 ABCB11 (0.51) SMN1; SMN2ABCB11ALOX15TP53ATM
SCHEMBL9642327 0.76 ABCB11 (0.51) SMN1; SMN2ABCB11ALOX15TP53ATM
SCHEMBL9643180 0.76 CHRM1 (0.49) SMN1; SMN2ABCB11TP53HPGDLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5091558-A Topical administeration SYNTEX (U.S.A.) INC. (US) 1992-02-25 US disclosed
EP-0150831-B1 NAPHTHALENE ANTI-PSORIATIC AGENTS SYNTEX (U.S.A.) INC. (US) 1988-08-10 EP disclosed
EP-0150831-A2 Naphthalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1985-08-07 EP disclosed